


Ask a doctor about a prescription for ENDOLEX 25 mg ORAL SOLUTION
Leaflet: Information for the user
Endolex 25 mg oral solution
Dexketoprofen
Read this leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the leaflet:
This medication is a pain reliever belonging to the group of medications called non-steroidal anti-inflammatory drugs (NSAIDs).
It is used for the short-term symptomatic treatment of acute pain of mild or moderate intensity, such as muscle or joint pain, menstrual pain (dysmenorrhea) or toothache.
Endolex is indicated for adult patients.
With dexketoprofen, cases of allergic reactions to this medication have been reported, including respiratory problems, swelling of the face and neck area (angioedema), and chest pain. Stop treatment with Endolex immediately and contact your doctor or the nearest emergency service if you notice any of these symptoms.
Do not take Endolex
Warnings and precautions
Consult your doctor or pharmacist before starting to take Endolex:
Children and adolescents
This medication has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and it should not be used in children or adolescents.
Infections
This medication may hide the signs of an infection, such as fever and pain. Consequently, this medication may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Avoid using the medication if you have chickenpox.
Other medications and Endolex
Inform your doctor or pharmacist if you are using or have recently used or may need to use any other medication, including those purchased without a prescription. There are some medications that should not be taken together, and other medications that may need a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medication, you are taking any of the following medications:
Not recommended combinations:
Combinations that require caution:
Combinations to be taken into account:
If you have any doubts about taking other medications with Endolex, consult your doctor or pharmacist.
Taking Endolex with food, drinks, and alcohol
In general, it is recommended to take it with meals to reduce the possibility of causing stomach upset (see also section 3, "Method of administration").
The use of NSAIDs in combination with alcohol may worsen the adverse reactions caused by the active ingredient.
Pregnancy, breastfeeding, and fertility
Do not take this medication during the last three months of pregnancy or during breastfeeding. It may cause kidney and heart problems in your fetus. It may affect your and your baby's predisposition to bleeding and delay or prolong labor more than expected. You should not take dexketoprofen during the first six months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, dexketoprofen may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication, as it may not be suitable for you.
Women who are planning a pregnancy or are pregnant should avoid using this medication. Treatment at any time during pregnancy should only be done under the guidance of a doctor.
The use of this medication is not recommended while trying to conceive or while undergoing fertility studies.
Regarding the potential effects on female fertility, see also section 2, "Warnings and precautions"
Driving and using machines
This medication may slightly affect your ability to drive and use machines, as it may cause drowsiness or dizziness as side effects of treatment. If you notice these effects, do not use machines or drive until these symptoms disappear. Ask your doctor for advice.
Endolex contains methyl parahydroxybenzoate (E-218), sucrose, aspartame (E-951), and sodium
It may cause allergic reactions (possibly delayed) because it contains methyl parahydroxybenzoate.
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication. It may harm your teeth.
This medication contains 0.095 mg of aspartame in each sachet. Aspartame is a source of phenylalanine, which may be harmful in cases of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it properly.
This medication contains less than 1 mmol of sodium (23 mg) per sachet; i.e., it is essentially "sodium-free".
Follow the administration instructions for this medication contained in this leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
The dose you need of this medication may vary, depending on the type, intensity, and duration of the pain.
The lowest effective dose should be used for the shortest necessary time to relieve symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
If the pain persists for more than 4 days, you should stop treatment and consult your doctor.
Adults from 18 years old
In general, it is recommended to take 1 sachet (25 mg of dexketoprofen) every 8 hours, not exceeding 3 sachets per day (75 mg).
If you are an elderly person or have kidney or liver disease, it is recommended to start treatment with a maximum of 2 sachets per day (50 mg). In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if the medication has been well tolerated.
Use in children and adolescents
This medication should not be used in children and adolescents (under 18 years old).
Instructions for proper use
The oral solution can be taken directly from the sachet or after pouring the contents into a glass of water. Once the sachet is opened, consume its entire contents.
Take the medication with food, as this helps reduce the risk of experiencing adverse effects on the stomach or intestine. However, if your pain is intense and you need quick relief, take the sachets on an empty stomach (at least 15 minutes before meals) as they will be absorbed more easily.
If you take more Endolex than you should
If you have taken too much medication, inform your doctor or pharmacist immediately or go to the emergency department of your nearest hospital or call the Toxicology Information Service, phone: 91.562.04.20, indicating the medication and the amount taken. Please remember to always carry the medication packaging or this leaflet with you.
If you forget to take Endolex
Do not take a double dose to make up for forgotten doses. Take the next dose when scheduled (according to section 3 "How to take Endolex").
If you have doubts about the use of this medication, consult your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Possible adverse effects are detailed below according to their frequency.
Due to the fact that the plasma concentration levels of dexketoprofen achieved with the oral solution pharmaceutical form are higher than those obtained with tablets, a potential increase in the risk of adverse reactions (gastrointestinal) cannot be ruled out.
Frequent Adverse Effects(may affect up to 1 in 10 people):
Nausea and/or vomiting, stomach pain, diarrhea, digestive disorders (dyspepsia).
Uncommon Adverse Effects(may affect up to 1 in 100 people):
Dizzy sensation (vertigo), dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, stomach problems, constipation, dry mouth, flatulence, skin rash, fatigue, pain, febrile sensation, and chills, general malaise.
Rare Adverse Effects(may affect up to 1 in 1,000 people):
Peptic ulcer, peptic ulcer perforation, or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention, and peripheral edema (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very Rare(may affect up to 1 in 10,000 people):
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin, mouth, eye, and genital ulcers (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or lip and throat swelling (angioedema), difficulty breathing due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis, liver cell damage (hepatitis), blurred vision, ringing in the ears (tinnitus), sensitive skin, sensitivity to light, itching, kidney problems. Decrease in the number of white blood cells (neutropenia), decrease in the number of platelets (thrombocytopenia).
Adverse Effects of Unknown Frequency (frequency cannot be determined from available data):
Chest pain, which may be a symptom of a potentially severe allergic reaction called Kounis syndrome. Fixed drug eruption: an allergic skin reaction known as a fixed drug eruption that may include round or oval red patches and skin swelling, blisters, and itching. There may also be darkening of the skin in the affected areas, which can persist after healing. The fixed drug eruption usually recurs in the same place or places if the medicine is taken again.
Inform your doctor immediately if you notice any adverse effect of a gastrointestinal type at the start of treatment (e.g., stomach pain or burning, or bleeding), if you have previously suffered from any of these adverse effects due to prolonged treatment with anti-inflammatory drugs, and especially if you are an elderly patient.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesion inside the mouth or genitals, or any other sign of an allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Endolex may be associated with a small increased risk of suffering a heart attack ("myocardial infarction") or stroke ("cerebrovascular accident").
In patients with immune system disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory drugs can rarely cause fever, headache, and neck stiffness.
The most commonly observed adverse effects are of a gastrointestinal type. Peptic ulcers, perforation, or gastrointestinal bleeding may occur, sometimes fatal, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, inflammation of the stomach wall (gastritis) has been observed.
As with other NSAIDs, aseptic meningitis may occur, which may predominantly affect patients with systemic lupus erythematosus or mixed connective tissue disease, and hematological reactions (purpura, aplastic anemia, and hemolytic anemia, and more rarely agranulocytosis and bone marrow hypoplasia).
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the national reporting system included in the Spanish Medicines Surveillance System for Human Use: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and carton. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Endolex
The active ingredient is dexketoprofen. Each sachet contains 25 mg of dexketoprofen corresponding to dexketoprofen trometamol 36.90 mg.
The other ingredients are: macrogol 400, methyl parahydroxybenzoate (E-218), sucralose, povidone, disodium phosphate, sodium dihydrogen phosphate dihydrate, purified water, flavoring (sucrose and aspartame (E-951)), and cola flavor.
Appearance ofEndolexand Package Contents
Transparent yellow-orange solution with a cola flavor in single-dose sachets of 10 ml.
It is presented in packages containing 10 sachets.
Marketing Authorization Holder and Manufacturer:
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa – Barcelona
Spain
Date of the Last Revision of this Prospectus:August 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ENDOLEX 25 mg ORAL SOLUTION – subject to medical assessment and local rules.